EFPIA - NEWSLETTER

EFPIA Newsletter 15 October 2026

News

15 October 2026 Towards a Single Regulatory Pathway for AI-Enabled Medical Technologies

We, the undersigned organisations representing healthcare professionals, researchers, innovators and industry across...

12 October 2026 EFPIA calls for pause in Urban Wastewater Treatment Directive implementation amid growing concerns...

Following today's meeting of the Ministers of Environment, EFPIA is again calling for a pause in the implementation...

Blogs

13 October 2026 Why Europe needs to rethink health security?

In recent years, health security has become one of the defining priorities of European policymaking. Yet the concept...

Events

19 OCT 2026

TOPRA Symposium 2026 Utrecht, The Netherlands

The 2026 TOPRA Symposium will bring together regulatory affairs professionals and thought leaders from across the healthcare...

Learn more →

17 NOV 2026

20th Global Forum for Qualified Persons for Pharmacovigilance (QPPV) Amsterdam, The Netherlands

20 years of QPPVs talking to QPPVs. The DIA Global QPPV Forum — a trusted space for QPPVs, NCPs and PV professionals...

Learn more →

What we are reading

‘Cut the crap’ – MEP Bosse on EU's slow response to US drug policy 15 October 2026 (Rapporteur)

MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised... 14 October 2026 (GOV.UK)

The UK doesn’t need a new clinical trials policy – it needs delivery 12 October 2026 (FT)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶